Novel Discoveries Targeting Gemcitabine‐based Chemoresistance and New Therapies in Pancreatic Cancer: How Far Are We From the Destination?

Cancer Medicine - United Kingdom
doi 10.1002/cam4.2384
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

How Far Are We From Periodontal Regeneration?

Journal of Oral Research
Dentistry
2015English

Lessons From Tarceva in Pancreatic Cancer: Where Are We Now, and How Should Future Trials Be Designed in Pancreatic Cancer?

Current Opinion in Oncology
Cancer ResearchOncology
2008English

How Far Are We From the Slippery Slope? The Laffer Curve Revisited

SSRN Electronic Journal
2011English

Targeting the Warburg Effect With a Novel Glucose Transporter Inhibitor to Overcome Gemcitabine Resistance in Pancreatic Cancer Cells

Carcinogenesis
MedicineCancer Research
2014English

Pharmacogenetics in Clinical Practice: How Far Have We Come and Where Are We Going?

Pharmacogenomics
Molecular MedicineGeneticsPharmacology
2013English

How Far Are We From Fully Automatic High Quality Grammatical Error Correction?

2015English

How Far Are We Away From Noninvasive Visualization of Histology in Vivo and in Situ?

2012English

How Close Are We to Therapies for Sanfilippo Disease?

Metabolic Brain Disease
BiochemistryMolecular NeuroscienceNeurologyCellular
2017English

Picosecond Diffraction at the ESRF: How Far Have We Come and Where Are We Going?

AIP Conference Proceedings
AstronomyPhysics
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy